Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
12/2002
12/05/2002US20020183325 Phthalazinone derivatives
12/05/2002US20020183324 Monocyclic or bicyclic carbocycles and heterocycles as factor Xa inhibitors
12/05/2002US20020183323 For therpay of inflammatory bowel disease, cerebral ischemia and arthritis, adult respiratory distress syndrome (ARDS) and myocarditis, as adjuvants to short term immunosuppression in transplant therapy
12/05/2002US20020183316 Amidoalkyl-piperidine and amidoalkyl-piperazine derivatives useful for the treatment of nervous system disorders
12/05/2002US20020183309 For therapy of acute myocardial infarction, asthma, bipolar disorder, cognitive enhancement, cognitive deficits in psychiatric disorders, cutaneous carcinoma, drug abuse, depression, gastrointestinal disorders, inflammation
12/05/2002US20020179105 Reduced ignition propensity smoking article
12/05/2002DE10126434A1 New tricyclic thiochromenone derivatives as metabotropic glutamate receptor-1 (mGluR1) antagonists useful for treating e.g. hemorrhagic stroke and atherosclerosis, especially pain or neurodegenerative diseases
12/05/2002CA2449118A1 Cdk inhibiting pyrimidines, production thereof and their use as medicaments
12/05/2002CA2448626A1 Carbamate and oxamide compounds as inhibitors of cytokine production
12/05/2002CA2447657A1 Use of compositions comprising cyclooxygenase-2 selective inhibitors in combination with radiation for inhibition or prevention of cardiovascular disease
12/05/2002CA2447475A1 Hydantion derivatives as inhibitors of matrix metalloproteinases
12/05/2002CA2411549A1 Ligands of integrin receptors
12/04/2002EP1262475A1 Indole derivatives, process for preparation of the same and use thereof
12/04/2002EP1261603A1 Flavone derivatives, preparation method and use as medicines
12/04/2002EP1261600A1 Heteroaromatic carboxamide derivatives and their use as inhibitors of the enzyme ikk-2
12/04/2002EP1261589A1 Imidazole compounds and their use as adenosine deaminase inhibitors
12/04/2002EP1261588A1 New imidazole derivatives
12/04/2002EP1261579A1 Dehydroamino acids
12/04/2002EP1261327A2 Adenosine receptor modulators
12/04/2002EP1077967B1 Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia
12/04/2002EP1001930B1 N-hydroxyformamide derivatives as inhibitors of matrix metalloproteinases
12/04/2002EP0912561B1 3-phenyl-furan-(5h)-2-one and dihydrofuran-2-one derivatives as antibacterial agents
12/04/2002CN1383427A Process for preparing N6-substituted deaza-adenosine derivatives
12/04/2002CN1383424A Aryl and heteroacrylcyclopropyl oxime ethers and their use as fungicides
12/03/2002US6489487 Triazolone derivatives, use thereof, and intermediates therefor
12/03/2002US6489452 An azo dye represented by the following general formula (1) and a process for making the azo dye is disclosed. the process comprises a step in which a diazonium salt is formed by the reaction between an aminopyrazole and aromatic coupling agent
12/03/2002US6489354 In particular, these compounds are useful as modulators of the chemokine receptors ccr-3 and/or ccr-5 useful in the treatment and prevention of atopic conditions including allergic rhinitis, dermatitis, conjunctivitis, and asthma
12/03/2002US6489344 For treatment diabetes in a human or animal subject
12/03/2002US6489324 Piperazine compounds as inhibitors of MMP or TNF
12/03/2002CA2074933C Thiazole derivatives as active superoxide radical inhibitors
11/2002
11/28/2002WO2002094820A1 Crystalline salts of 2-(4-{2-[2-hydroxy-3-(2-thiophen-2-yl-phenoxy)-propylamino]-2-methyl-propyl}-phenoxy)-nicotinonitrile
11/28/2002WO2002094812A1 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/28/2002WO2002094811A1 4-(penyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/28/2002WO2002094810A1 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/28/2002WO2002094809A1 3-quinoline-2-(1h)-ylideneindolin-2-one derivatives
11/28/2002WO2002094796A2 Benzo[g]quinoxaline derivatives as effective compounds against infectious diseases
11/28/2002WO2002094795A1 4-aminopyrimidine derivatives
11/28/2002WO2002094792A1 Herbicidal substituted benzoylpyrazoles
11/28/2002WO2002094789A1 Quinoline derivatives as ligands for the neuropeptide y receptor
11/28/2002WO2002094787A1 2-oxo-piperidinyl- and 2-oxo-azepanyl alkanoic acid derivativ es for the treatment of epilepsy and other neurological disorders
11/28/2002WO2002094786A1 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain anxiety or gastrointestinal disorders
11/28/2002WO2002094785A1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/28/2002WO2002094784A1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/28/2002WO2002094783A1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/28/2002WO2002094782A1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derativatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/28/2002WO2002094261A1 Cxcr4-antagonistic drugs comprising nitrogen-containing compound
11/28/2002WO2002094203A2 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
11/28/2002WO2002085897A8 Heterocyclic compounds for aging-related and diabetic vascular complications
11/28/2002WO2002000648A1 Imidazole derivatives or salts thereof and drugs containing the derivatives or the salts
11/28/2002US20020177723 Compounds and methods for the treatment of inflammatory and immune disorders
11/28/2002US20020177606 Useful as antibiotics against Staphylococcus, Streptococcus, Enterococcus and Moraxella
11/28/2002US20020177598 Inhibit activity of chemokines, macrophage inflammatory protein-1 (MIP-1 alpha) and RANTES; 1-((4-chlorophenoxy)methyl)-carbonyl-2-methyl-4-(4-fluorobenzyl)piperazine for example
11/28/2002US20020177589 Novel amines as histamine-3 receptor ligands and their therapeutic applications
11/28/2002US20020177588 Selectivity
11/28/2002US20020177578 3-hydroxy-4-methoxypyridine-2-carboxyamides N-substituted with a benzyl 9-member dilactone ring
11/28/2002DE10138577A1 New 4-benzoyl-5-oxy-pyrazole derivatives, useful as herbicides, especially pre- and post-emergence selective herbicides
11/28/2002DE10123574A1 New heterocyclylmethyl-substituted anthranilamide derivatives and analogs as KDR/FLT tyrosine kinase inhibitors, used for treating e.g. psoriasis, restenosis, leukemia, arthritis, eye or kidney disease or arteriosclerosis
11/28/2002CA2448076A1 3-quinoline-2-(1h)-ylideneindolin-2-one derivatives
11/28/2002CA2447674A1 Herbicidal substituted benzoylpyrazoles
11/28/2002CA2447103A1 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
11/28/2002CA2447020A1 The use of 4-aminopyridine derivatives for the treatment of mglur5 receptor mediated diseases
11/28/2002CA2446516A1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/28/2002CA2446332A1 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/28/2002CA2446331A1 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/28/2002CA2446324A1 Quinoline derivatives as ligands for the neuropeptide y receptor
11/28/2002CA2446316A1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/28/2002CA2446313A1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/28/2002CA2446311A1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derativatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/28/2002CA2446155A1 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain anxiety or gastrointestinal disorders
11/28/2002CA2446154A1 4-(penyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/28/2002CA2410391A1 Imidazole derivatives or salts thereof and drugs containing the derivatives or the salts
11/27/2002EP1260512A1 Novel cyclic amide derivatives
11/27/2002EP1260223A1 Taxanes having furyl or thienyl substituted side-chain
11/27/2002EP1259491A1 4-imidazole derivatives of benzyl and restricted benzyl sulfonamides, sulfamides, ureas, carbamates and amides and their use as alpha-1a agonists
11/27/2002EP1259485A2 BENZAMIDES AND RELATED INHIBITORS OF FACTOR Xa
11/27/2002EP1114024B1 Urokinase inhibitors
11/27/2002EP1001934B1 Indole compounds as cox-2 inhibitors
11/27/2002EP0825982B1 Alkyl dihalogenated phenyl-substituted ketoenols useful as pesticides and herbicides
11/27/2002CN1382150A Hydromycin derivatives
11/27/2002CN1382138A Piperidine derivatives as reuptake inhibitors
11/27/2002CN1382137A Thtrahydrothiopy 2,3-diazanaphthylaone derivatives as PDE inhibitors
11/27/2002CN1382136A N-heterocyclic derivatives as NOS inhibitors
11/27/2002CN1382135A Amine and amide derivatives as ligands for neuropeptide YY5 receptor usefu in treatment of obesity and other disorders
11/27/2002CN1382124A Bicycle androgen and progesterone receptor modulator compounds and methods
11/27/2002CN1094939C Microbiocidal benzotriazoles compounds, making method and use
11/26/2002US6486173 Serotonin-7 (5-ht7); treatment of central nervous system disorders such as sleep disorders, depression and schizophrenia; for example 1,3-dihydro-2-((4-(4-fluorophenyl)-4-oxobutyl))isoindole
11/26/2002US6486171 Useful in the treatment of some central nervous system disorders including as an antidepressant; 4-(1-(2-naphthyl)ethyl)-4- piperidinyl)thieno(3,2-c)pyridine, for example
11/26/2002US6486156 Chemical compounds
11/26/2002US6486153 Phenylindole derivatives as 5-HT2A receptor ligands
11/21/2002WO2002093164A2 Pyridylpyrimidine derivatives as effective compounds against prion diseases
11/21/2002WO2002092591A1 Acrylic esters and use thereof
11/21/2002WO2002092590A1 Furan and thiophene derivatives that activate human peroxisome proliferator activated receptors
11/21/2002WO2002092588A2 Aromatic sulfone hydroxamates and their use as protease inhibitors
11/21/2002WO2002092585A1 Novel, arylsusfonamide compounds for the treatment of obesity, type ii diabetes and cns-disorders
11/21/2002WO2002092575A1 Benzimidazole compounds and antiviral uses thereof
11/21/2002WO2002092573A2 Heterocyclic substituted pyrazoles as inhibitors of src and other protein kinases
11/21/2002WO2002092571A1 Novel 4-anilinoquinoline-3-carboxamides
11/21/2002WO2002092568A1 5-cyano-1h-indole derivatives as antagonists of the interleukine-8 receptors
11/21/2002WO2002092563A2 Protease inhibitors
11/21/2002WO2002092087A1 2,5-disubstituted pyridine, pyrimidine, pyridazine and 1, 2, 4-triazine derivatives for use as p38 inhibitors
1 ... 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 ... 523